LobbyingAtterx Biotherapeutics lobbying by quarter
Atterx Biotherapeutics's latest lobbying report covers Q2 2026, at $15K. The four quarters Q4 2025–Q3 2026 total $45K. Its first report covers Q2 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.
Atterx Biotherapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $45K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $15K | 1 |
| Q3 2023 | $15K | 1 |
| Q4 2023 | $15K | 1 |
| Q1 2024 | $15K | 1 |
| Q2 2024 | $15K | 1 |
| Q3 2024 | $15K | 1 |
| Q4 2024 | $15K | 1 |
| Q1 2025 | $15K | 1 |
| Q2 2025 | $15K | 1 |
| Q3 2025 | $15K | 1 |
| Q4 2025 | $15K | 1 |
| Q1 2026 | $15K | 1 |
| Q2 2026 | $15K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$195K · 13 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE13 reports
Firms it paid
| Firm | ||
|---|---|---|
| Capstone National Partners | $195K | 13 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| WILLIAM STONE | Chief of Staff, Congressman Dave Obey | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Capstone National Partners | $15K |
| 05/18for Q1 | Capstone National Partners | $15K |
| 01/08for Q4 2025 | Capstone National Partners | $15K |
| 25/10/06for Q3 2025 | Capstone National Partners | $15K |
| 25/07/02for Q2 2025 | Capstone National Partners | $15K |
| 25/05/05for Q1 2025 | Capstone National Partners | $15K |
| 25/01/06for Q4 2024 | Capstone National Partners | $15K |
| 24/11/07for Q3 2024 | Capstone National Partners | $15K |
| 24/07/03for Q2 2024 | Capstone National Partners | $15K |
| 24/04/04for Q1 2024 | Capstone National Partners | $15K |
| 24/01/09for Q4 2023 | Capstone National Partners | $15K |
| 23/10/19for Q3 2023 | Capstone National Partners | $15K |
| 23/08/28for Q2 2023 | Capstone National Partners | $15K |
| 23/07/11for Q2 2023 | Capstone National Partners | Under $5,000 |